|
 |
|
|||||||
|
|||||||||
Diabetes 51:3428-3434, 2002
© 2002 by the American Diabetes Association, Inc.
Intrahepatic Islet Transplantation in Type 1 Diabetic Patients Does Not Restore Hypoglycemic Hormonal Counterregulation or Symptom Recognition After Insulin Independence
1 Clinical Islet Transplant Program, University of Alberta, Edmonton, Alberta, Canada
2 Pacific Northwest Research Institute, Seattle, Washington
Islet allotransplantation can provide prolonged insulin independence in selected individuals with type 1 diabetes. Whether islet transplantation also restores hypoglycemic counterregulation is unclear. To determine if hypoglycemic counterregulation is restored by islet transplantation, we studied hormone responses and hypoglycemic symptom recognition in seven insulin-independent islet transplant recipients using a 3-h stepped hypoglycemic clamp, and compared their responses to those of nontransplanted type 1 diabetic subjects and nondiabetic control subjects. Glucagon responses of islet transplant recipients to hypoglycemia were significantly less than that observed in control subjects (incremental glucagon [mean ± SE]: -12 ± 12 vs. 64 ± 22 pg/ml, respectively; P < 0.05), and not significantly different from that of nontransplanted type 1 diabetic subjects (-17 ± 10 pg/ml). Epinephrine responses and symptom recognition were also not restored by islet transplantation (incremental epinephrine [mean ± SE]: 195 ± 128 [islet transplant recipients] vs. 238 ± 73 [type 1 diabetic subjects] vs. 633 ± 139 pg/ml [nondiabetic control subjects], P < 0.05 vs. control; peak symptom scores: 3.3 ± 0.9 [islet transplant recipients] vs. 3.1 ± 1.1 [type 1 diabetic subjects] vs. 6.7 ± 0.8 [nondiabetic control subjects]). Thus the results indicate that despite providing prolonged insulin independence and near-normal glycemic control in these patients with long-standing type 1 diabetes, hypoglycemic hormonal counterregulation and symptom recognition were not restored by intrahepatic islet transplantation.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Bollyky and C. J. Greenbaum The Role of Glucagon in Postprandial Hyperglycemia The Jury's Still Out J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2879 - 2881. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lau, G. Mattsson, C. Carlsson, D. Nyqvist, M. Kohler, P.-O. Berggren, L. Jansson, and P.-O. Carlsson Implantation Site-Dependent Dysfunction of Transplanted Pancreatic Islets Diabetes, June 1, 2007; 56(6): 1544 - 1550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Meyer, A. Vaksman, D. M. Thompson, M. A. Fung, G. L. Warnock, A.M. J. Shapiro, C. Ricordi, and B. J. Hering Islet transplantation. N. Engl. J. Med., March 1, 2007; 356(9): 963 - 964. [Full Text] [PDF]
|
|
|
|
|
|
M. R. Rickels, M. H. Schutta, R. Mueller, S. Kapoor, J. F. Markmann, A. Naji, and K. L. Teff Glycemic Thresholds for Activation of Counterregulatory Hormone and Symptom Responses in Islet Transplant Recipients J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 873 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gromada, I. Franklin, and C. B. Wollheim {alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains Endocr. Rev., February 1, 2007; 28(1): 84 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Rickels, M. H. Schutta, R. Mueller, J. F. Markmann, C. F. Barker, A. Naji, and K. L. Teff Islet Cell Hormonal Responses to Hypoglycemia After Human Islet Transplantation for Type 1 Diabetes Diabetes, November 1, 2005; 54(11): 3205 - 3211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Raju and P. E. Cryer Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon? Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E181 - E186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Ryan, B. W. Paty, P. A. Senior, D. Bigam, E. Alfadhli, N. M. Kneteman, J. R.T. Lakey, and A.M. J. Shapiro Five-Year Follow-Up After Clinical Islet Transplantation Diabetes, July 1, 2005; 54(7): 2060 - 2069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Zaman, K. D. Abreo, S. Levine, W. Maley, and G. B. Zibari Pancreatic Transplantation: Evaluation and Management J Intensive Care Med, May 1, 2004; 19(3): 127 - 139. [Abstract] [PDF]
|
|
|
|
|
|
G. Mattsson, L. Jansson, A. Nordin, A. Andersson, and P.-O. Carlsson Evidence of Functional Impairment of Syngeneically Transplanted Mouse Pancreatic Islets Retrieved from the Liver Diabetes, April 1, 2004; 53(4): 948 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Robertson Islet Transplantation as a Treatment for Diabetes -- A Work in Progress N. Engl. J. Med., February 12, 2004; 350(7): 694 - 705. [Full Text] [PDF]
|
|
|
|
|
|
A. Omer, V. F. Duvivier-Kali, W. Aschenbach, V. Tchipashvili, L. J. Goodyear, and G. C. Weir Exercise Induces Hypoglycemia in Rats With Islet Transplantation Diabetes, February 1, 2004; 53(2): 360 - 365. [Abstract] [Full Text]
|
|
|
|
|
|
R. P. Robertson, D. E.R. Sutherland, E. R. Seaquist, and K. J. Lanz Glucagon, Catecholamine, and Symptom Responses to Hypoglycemia in Living Donors of Pancreas Segments Diabetes, July 1, 2003; 52(7): 1689 - 1694. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |